Neutrophil-to-lymphocyte ratio is independently associated with carotid atherosclerosis burden in individuals with type 1 diabetes

Libby, 2019, Atherosclerosis, Nature reviews disease primers, 5, 1, 10.1038/s41572-019-0106-z Rawshani, 2017, Mortality and cardiovascular disease in type 1 and type 2 diabetes, N Engl J Med, 376, 1407, 10.1056/NEJMoa1608664 Harjutsalo, 2021, Long-term population-based trends in the incidence of cardiovascular disease in individuals with type 1 diabetes from Finland: a retrospective, nationwide, cohort study, Lancet Diabetes Endocrinol, 9, 575, 10.1016/S2213-8587(21)00172-8 Swastini, 2019, Atherosclerosis prediction with high sensitivity C-reactive protein (hs-CRP) and related risk factor in patient with dyslipidemia, Open Access Maced J Med Sci, 7, 3887, 10.3889/oamjms.2019.526 Fani, 2021, Circulatory markers of immunity and carotid atherosclerotic plaque, Atherosclerosis, 325, 69, 10.1016/j.atherosclerosis.2021.03.040 Libby, 2021, The changing landscape of atherosclerosis, Nature, 592, 524, 10.1038/s41586-021-03392-8 Katsarou, 2017, Type 1 diabetes mellitus, Nat Rev Dis Prim, 3 Song, 2021, Neutrophil-to-lymphocyte ratio and mortality in the United States general population, Sci Rep, 11, 1 Fest, 2018, Reference values for white blood-cell-based inflammatory markers in the Rotterdam Study: a population-based prospective cohort study, Sci Rep, 8, 10.1038/s41598-018-28646-w Meng, 2018, Neutrophils and neutrophil-lymphocyte ratio: inflammatory markers associated with intimal-media thickness of atherosclerosis, Thromb Res, 170, 45, 10.1016/j.thromres.2018.08.002 Di Bonito, 2019, Non-albuminuric reduced eGFR phenotype in children and adolescents with type 1 diabetes, Diabetes Res Clin Pract, 155, 10.1016/j.diabres.2019.07.005 Salah, 2022, Leukocytic dysregulation in children with type 1 diabetes: relation to diabetic vascular complications, Diabetol Int, 13, 538, 10.1007/s13340-021-00568-5 Ayhan, 2015, Relationship of neutrophil-to-lymphocyte ratio with aortic stiffness in type 1 diabetes mellitus, Can J Diabetes, 39, 317, 10.1016/j.jcjd.2015.01.004 Jansa, 2015, Psychometric analysis of the Spanish and Catalan versions of a questionnaire for hypoglycemia awareness, Medicina Clínica (English Edition, 144, 440, 10.1016/j.medcle.2015.12.012 Clarke, 1995, Reduced awareness of hypoglycemia in adults with IDDM. A prospective study of hypoglycemic frequency and associated symptoms, Diabetes Care, 18, 517, 10.2337/diacare.18.4.517 Bedogni, 2006, The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population, BMC Gastroenterol, 6, 33, 10.1186/1471-230X-6-33 Pané, 2020, Insulin resistance is associated with preclinical carotid atherosclerosis in patients with type 1 diabetes, Diabetes Metab Res Rev, e3323, 10.1002/dmrr.3323 Mesa, 2022, Hyperglycemia and hypoglycemia exposure are differentially associated with micro- and macrovascular complications in adults with Type 1 Diabetes, Diabetes Res Clin Pract, 189, 10.1016/j.diabres.2022.109938 Touboul, 2012, Mannheim carotid intima-media thickness and plaque consensus (2004-2006-2011), Cerebrovasc Dis, 34, 290, 10.1159/000343145 Packard, 2009, Innate and adaptive immunity in atherosclerosis, Semin Immunopathol, 31, 5, 10.1007/s00281-009-0153-8 Visseren, 2021, 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice, Eur Heart J, 42, 3227, 10.1093/eurheartj/ehab484 Targher, 2005, Increased plasma markers of inflammation and endothelial dysfunction and their association with microvascular complications in Type 1 diabetic patients without clinically manifest macroangiopathy, Diabet Med, 22, 999, 10.1111/j.1464-5491.2005.01562.x Aulich, 2019, Associations between circulating inflammatory markers, diabetes type and complications in youth, Pediatr Diabetes, 20, 1118, 10.1111/pedi.12913 Snell-Bergeon, 2010, Inflammatory markers are increased in youth with type 1 diabetes: the SEARCH Case-Control study, J Clin Endocrinol Metab, 95, 2868, 10.1210/jc.2009-1993 Amor, 2020, Advanced lipoprotein profile disturbances in type 1 diabetes mellitus: a focus on LDL particles, Cardiovasc Diabetol, 19, 126, 10.1186/s12933-020-01099-0 Yang, 2020, Systemic immune-inflammation index (SII) predicted clinical outcome in patients with coronary artery disease, Eur J Clin Invest, 50, 10.1111/eci.13230 Adamstein, 2021, The neutrophil-lymphocyte ratio and incident atherosclerotic events: analyses from five contemporary randomized trials, Eur Heart J, 42, 896, 10.1093/eurheartj/ehaa1034 Fani, 2020, The association of innate and adaptive immunity, subclinical atherosclerosis, and cardiovascular disease in the Rotterdam Study: a prospective cohort study, PLoS Med, 17, 10.1371/journal.pmed.1003115 Ridker, 2017, Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial, Lancet, 390, 1833, 10.1016/S0140-6736(17)32247-X Serés-Noriega, 2022, Use of the steno T1 risk engine identifies preclinical atherosclerosis better than use of ESC/EASD-2019 in adult subjects with type 1 diabetes at high risk, Diabetes Care, 45, 2412, 10.2337/dc22-0118 Amor, 2021, Novel glycoproteins identify preclinical atherosclerosis among women with previous preeclampsia regardless of type 1 diabetes status, Nutr Metabol Cardiovasc Dis, 31, 3407, 10.1016/j.numecd.2021.08.041 Serés-Noriega, 2021, Quantification of glycoproteins by nuclear magnetic resonance associated with preclinical carotid atherosclerosis in patients with type 1 diabetes, Nutr Metabol Cardiovasc Dis, 31, 2099, 10.1016/j.numecd.2021.03.021 Soehnlein, 2012, Multiple roles for neutrophils in atherosclerosis, Circ Res, 110, 875, 10.1161/CIRCRESAHA.111.257535 Abo, 2002, Immunomodulation by the autonomic nervous system: therapeutic approach for cancer, collagen diseases, and inflammatory bowel diseases, Ther Apher, 6, 348, 10.1046/j.1526-0968.2002.00452.x Feng, 2022, The role of interleukin-6 family members in cardiovascular diseases, Front Cardiovasc Med, 9, 10.3389/fcvm.2022.818890 Yuan, 2020, Effects of tumour necrosis factor on cardiovascular disease and cancer: a two-sample Mendelian randomization study, EBioMedicine, 59, 10.1016/j.ebiom.2020.102956 Gepner, 2015, Comparison of coronary artery calcium presence, carotid plaque presence, and carotid intima-media thickness for cardiovascular disease prediction in the multi-ethnic study of atherosclerosis, Circ Cardiovasc Imaging, 8, 10.1161/CIRCIMAGING.114.002262 Fernandez, 2019, Single-cell immune landscape of human atherosclerotic plaques, Nat Med, 25, 1576, 10.1038/s41591-019-0590-4 Tanigawa, 2003, Relationships of differential leukocyte and lymphocyte subpopulations with carotid atherosclerosis in elderly men, J Clin Immunol, 23, 469, 10.1023/B:JOCI.0000010423.65719.e5 Pop-Busui, 2010, Effects of cardiac autonomic dysfunction on mortality risk in the action to control cardiovascular risk in diabetes (ACCORD) trial, Diabetes Care, 33, 1578, 10.2337/dc10-0125 Boswell, 2023, Diabetic neuropathy is independently associated with worse graft outcomes and incident cardiovascular disease after pancreas transplantation: a retrospective cohort study in type 1 diabetes, Transplantation, 107, 475, 10.1097/TP.0000000000004275